Get started
Author

Erik W. Muller

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
2018 · Annemieke Cats, Edwin P M Jansen, et al. · The Lancet Oncology · 566
Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial
2014 · A.J. Breugom, W. van Gijn, et al. · Annals of Oncology · 393
Lethal outcome of a patient with a complete dihydropyrimidine dehydrogenase (DPD) deficiency after administration of 5-fluorouracil: frequency of the common IVS14+1G>A mutation causing DPD deficiency.
2001 · A B van Kuilenburg, E W Muller, et al. · PubMed · 254
Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial
2017 · Vivianne C G Tjan-Heijnen, Irene E G van Hellemond, et al. · The Lancet Oncology · 153
Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy
2011 · Lieke H.J. Simkens, Miriam Koopman, et al. · European Journal of Cancer · 96
PDF
Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group
2017 · J.J.M. Kwakman, L.H.J. Simkens, et al. · Annals of Oncology · 79
Randomized Phase II Study Comparing Efficacy and Safety of Combination-Therapy Trastuzumab and Docetaxel vs. Sequential Therapy of Trastuzumab Followed by Docetaxel Alone at Progression As First-Line Chemotherapy in Patients with HER2+ Metastatic Breast Cancer: HERTAX Trial
2011 · Paul Hamberg, Monique M.E.M. Bos, et al. · Clinical Breast Cancer · 62
PDF
Primary Granulocyte Colony-Stimulating Factor Prophylaxis During the First Two Cycles Only or Throughout All Chemotherapy Cycles in Patients With Breast Cancer at Risk for Febrile Neutropenia
2013 · Maureen J. Aarts, Frank P. Peters, et al. · Journal of Clinical Oncology · 49
Cost Effectiveness of Primary Pegfilgrastim Prophylaxis in Patients With Breast Cancer at Risk of Febrile Neutropenia
2013 · Maureen J. Aarts, Janneke P. Grutters, et al. · Journal of Clinical Oncology · 41
Trimetrexate as biochemical modulator of 5-fluorouracil/leucovorin in advanced colorectal cancer: final results of a randomised European study
2002 · C.J.A. Punt, H.J. Keizer, et al. · Annals of Oncology · 27
PDF
Differences in puromycin aminonucleoside nephrosis in two rat strains
1988 · Joris Grond, Erik W. Muller, et al. · Kidney International · 23
Reversible Posterior Leukoencephalopathy Syndrome Caused by Bevacizumab: Report of a Case
2008 · Miriam Koopman, Erik W. Muller, et al. · Diseases of the Colon & Rectum · 22
Fatal pneumonitis after treatment with docetaxel and trastuzumab.
2009 · E Kuip, E Muller · PubMed · 20
Informal caregiver well-being during and after patients’ treatment with adjuvant chemotherapy for colon cancer: a prospective, exploratory study
2020 · S. M. C. H. Langenberg, H. Poort, et al. · Supportive Care in Cancer · 17
PDF
Lymphohaemopoietic antigens of cultured human glomerular epithelial cells.
1989 · F J van der Woude, A F Michael, et al. · PubMed Central · 14
Explantation of mesangial cell 'hillocks': a method for obtaining human mesangial cells in culture.
1992 · E W Muller, Y Kim, et al. · Europe PMC (PubMed Central) · 12
Successful Immunosuppressive Treatment After Failure of Erythropoietin Therapy in Two Subjects With Refractory Anaemia
1993 · Erik W. Muller, Joost Th. M. de Wolf, et al. · British Journal of Haematology · 6
Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group
2019 · Johannes J.M. Kwakman, Erik van Werkhoven, et al. · Clinical Colorectal Cancer · 5
Randomized phase 3 study of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer (mCRC): The SALTO study of the Dutch Colorectal Cancer Group.
2016 · Cornelis J. A. Punt, Lieke H Simkens, et al. · Journal of Clinical Oncology · 3
[Acute coronary syndrome after chemotherapy].
2014 · Mijntje B Vastbinder, Henk Drost, et al. · PubMed · 3
Randomised phase 3 study of S-1 versus capecitabine, with bevacizumab optional in both arms, in the first-line treatment of metastatic colorectal cancer (mCRC), the SALTO study of the Dutch Colorectal Cancer Group
2017 · J.J.M. Kwakman, L.H.J. Simkens, et al. · European Journal of Cancer · 1
Phase III trial of 5-fluorouracil (5FU) and leucovorin (LV) with or without trimetrexate (TMTX) as first line treatment in advanced colorectal cancer (ACC)
1999 · C.J.A. Punt, H.J. Keizer, et al. · European Journal of Cancer · 1
Failure of subcutaneous vasopressin in diagnosis of central diabetes insipidus
1993 · ErikW. Muller, ArmandR.J. Girbes · The Lancet · 1
Updated survival analysis of the randomized phase III trial comparing S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer (SALTO) by the Dutch colorectal cancer group
2019 · J.J. Kwakman, E. Van Werkhoven, et al. · Annals of Oncology
Adjuvant endocrine treatment: Stop or continue?
2017 · E.W. Muller, A. van de Wouw, et al. · Annals of Oncology
PDF
Works count: 28
Citation count: 1,848
H-index: 14
I10-index: 16
Year
Topic
Type